Anakinra
Orphan Drug Cold Chain RequiredFDA Approved
Contents
Description
Anakinra is an interleukin-1 receptor antagonist (IL-1Ra) used to treat several inflammatory conditions. It works by blocking the effects of IL-1, a protein that causes inflammation.
Indications & Therapeutic Use
Cryopyrin-Associated Periodic Syndromes (CAPS)
Global Availability (5 countries)
| Country | Access Route | Regulatory Pathway | Lead Time | Status |
|---|---|---|---|---|
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — |
Buy / Source Anakinra — GNH India
19 matching products available through GNH India. Select a product to view details and request a quote on the GNH India website.
Browse all Anakinra products on GNH IndiaProducts and ordering are fulfilled by GNH India. You will be redirected to www.gnhindia.com.
Available Through
This drug is available for procurement through the following fulfilment partner.
Fulfilment Partner
Anakinra
| Generic Name | Anakinra |
| Brands | 1 brand available |
| Active Ingredient | Anakinra |
| Drug Class | Cryopyrin-Associated Periodic Syndromes (CAPS) |
| Manufacturer | Swedish Orphan Biovitrum AB |
| Dosage Forms | Subcutaneous injection |
| Medical Code | L04AC04 |
| Orphan Status | Yes — Orphan Drug |
| Cold Chain | Required |
| Lead Time | 14 days |
| Reg. Status | FDA Approved |
| Clinical Trial | NCT00397340 |
| Countries | 5 countries |
Authority Signals
Last Verified3/21/2026
Data ConfidenceHigh (AI + Pharmacist)
Source Citations6 Validated Nodes